Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Net Cash Flow (2019 - 2025)

Volitionrx (VNRX) has disclosed Net Cash Flow for 9 consecutive years, with -$2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Cash Flow fell 2666.07% year-over-year to -$2.0 million, compared with a TTM value of -$6.7 million through Sep 2025, down 46.3%, and an annual FY2024 reading of -$17.8 million, down 281.07% over the prior year.
  • Net Cash Flow was -$2.0 million for Q3 2025 at Volitionrx, down from -$669448.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $13.6 million in Q1 2021 and bottomed at -$9.0 million in Q3 2023.
  • Average Net Cash Flow over 5 years is -$1.1 million, with a median of -$2.0 million recorded in 2025.
  • Peak annual rise in Net Cash Flow hit 354.31% in 2021, while the deepest fall reached 4367.05% in 2021.
  • Year by year, Net Cash Flow stood at -$2.4 million in 2021, then crashed by 123.58% to -$5.5 million in 2022, then surged by 281.61% to $9.9 million in 2023, then plummeted by 133.7% to -$3.3 million in 2024, then skyrocketed by 39.19% to -$2.0 million in 2025.
  • Business Quant data shows Net Cash Flow for VNRX at -$2.0 million in Q3 2025, -$669448.0 in Q2 2025, and -$632746.0 in Q1 2025.